Refine Results
  1. "Churchill Livingstone"
Formats
  1. Book Section (35)
  2. Journal Article (32)
  3. Review (7)
  4. Meeting Abstract (5)
  5. Book Whole (4)
  6. Correspondence (2)
  7. Editorial (1)
Groups
  1. Department of Medicine (20)
  2. Center for Hematologic Malignancies (18)
  3. Hematologic Malignancies, Division of (17)
  4. Bone Marrow Transplant (10)
  5. Survivorship Research (9)
  6. Surgery (8)

More Groups

People
  1. Robert Ginsberg (11)
  2. D Dershaw (5)
  3. Sergio Giralt (5)
  4. Charles Inturrisi (4)
  5. Amitabh Gulati (3)
  6. Heather Landau (3)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (4)
  4. 2019 (2)
  5. 2018 (4)
  6. 2017 (1)

More Years

Publications
  1. Thoracic Surgery (18)
  2. Blood Reviews (17)
  3. Journal of Pain (13)
  4. Interventional Breast Procedures (7)
  5. Cardiac, Vascular, and Thoracic Anesthesia (5)
  6. Hematology: Basic Principles and Practice. 3rd ed (4)

More Publications

Publishers
  1. Churchill Livingstone (86)

Results (86)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A review of FLT3 inhibitors in acute myeloid leukemia
    Review

    Zhao, J. C.; Agarwal, S.; Ahmad, H.; Amin, K.; Bewersdorf, J. P.; Zeidan, A. M.
    Blood Reviews (2022)

    Fulltext@MSK | Save
  • Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization
    Review

    Chen, J.; Lazarus, H. M.; Dahi, P. B.; Avecilla, S.; Giralt, S. A.
    Blood Reviews (2021)

    Fulltext@MSK | Save
  • The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation
    Review

    Nawas, M. T.; Schetelig, J.; Damm, F.; Levine, R. L.; Perales, M. A.; Giralt, S. A.; VanDenBrink, M. R.; Arcila, M. E.; Zehir, A.; Papaemmanuil, E.; more...
    Blood Reviews (2021)

    Fulltext@MSK | Save
  • Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity
    Review

    Diamond, B. T.; Rustad, E.; Maclachlan, K.; Thoren, K.; Ho, C.; Roshal, M.; Ulaner, G. A.; Landgren, C. O.
    Blood Reviews (2021)

    Fulltext@MSK | Save
  • Response to letter to the editor on “Assessment of a satisfaction measure for use after primary total joint arthroplasty”
    Correspondence

    Goodman, S. M.; Mehta, B. Y.; Kahlenberg, C. A.; Krell, E. C.; Nguyen, J.; Finik, J.; Figgie, M. P.; Parks, M. L.; Padgett, D. E.; Antao, V. C.; more...
    Journal of Arthroplasty (2020)

    Fulltext@MSK | Save
  • Dental intervention for the irradiated patient: Time to re-evaluate dental treatment algorithms?
    Editorial

    Rosen, E. B.; Ahmed, Z. U.; Randazzo, J. D.; Yom, S.; Estilo, C. L.; Huryn, J. M.
    British Journal of Oral and Maxillofacial Surgery (2020)

    Fulltext@MSK | Save
  • Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy
    Review

    Bachanova, V.; Perales, M. A.; Abramson, J. S.
    Blood Reviews (2020)

    Fulltext@MSK | Save
  • Letter to the editor on “A meta-analysis of outcomes in total hip arthroplasty recipients following pelvic irradiation”
    Correspondence

    Christ, A. B.; Healey, J. H.; Fabbri, N.
    Journal of Arthroplasty (2020)

    Fulltext@MSK | Save
  • CAR-T – and a side order of IgG, to go? – Immunoglobulin replacement in patients receiving CAR-T cell therapy
    Review

    Hill, J. A.; Giralt, S.; Torgerson, T. R.; Lazarus, H. M.
    Blood Reviews (2019)

    Fulltext@MSK | Save
  • Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
    Review

    Liu, Y.; Bewersdorf, J. P.; Stahl, M.; Zeidan, A. M.
    Blood Reviews (2019)

    Fulltext@MSK | Save